BMS-813160

• Description:

  BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  484.64

• Molecular Formula:

  C25H40N8O2

• Notes:

  Research use only, not for human use.

• Receptor:

  CCR2|CCR5

• CAS Number:

  1286279-29-5